Synergy between dendritic cells and GM-CSF-secreting tumor cells for the treatment of a murine renal cell carcinoma

Journal of Immunotherapy

Volumn 32, Issue 2, 2009, Pages 140-144

  Driessens, Gregory ^a   Hoffmann, Paul ^a,b   Pouwels, Michael ^a   Zlotta, Alexandre ^b   Schulman, Claude ^b   Velu, Thierry ^a,c   Bruyns, Catherine A ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b ERASME HOSPITAL   (Belgium)

^c Centre Hospitalier interregional Edith Cavell   (Belgium)

Author keywords

Cancer vaccines; Dendritic cells; GM CSF; Renal cell carcinoma

Indexed keywords

DENDRITIC CELL VACCINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR VACCINE; CANCER VACCINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DRUG POTENTIATION; EMBRYO; GENETIC TRANSDUCTION; IMMUNE RESPONSE; KIDNEY CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT RESPONSE; TUMOR CELL; VACCINATION; ANIMAL; BAGG ALBINO MOUSE; CD8+ T LYMPHOCYTE; DENDRITIC CELL; GENETICS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; IMMUNOTHERAPY; KIDNEY TUMOR; METABOLISM; METHODOLOGY; TRANSPLANTATION;

ANIMALS; CANCER VACCINES; CARCINOMA, RENAL CELL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNOLOGIC MEMORY; IMMUNOTHERAPY; INTERFERON-GAMMA; KIDNEY NEOPLASMS; MICE; MICE, INBRED BALB C; TRANSDUCTION, GENETIC;

EID: 63649117277     PISSN: 15249557     EISSN: None     Source Type: Journal    
DOI: 10.1097/CJI.0b013e3181920275     Document Type: Article

References (15)

1. Jemal A, Siegel R, Ward E, et al. Cancer Statistics, 2008. CA Cancer J Clin. 2008;58:71-96.
2. Pyrhonen SO. Systemic therapy in metastatic renal cell carcinoma. Scand J Surg. 2004;93:156-161.
3. Clark PE. Recent advances in targeted therapy for renal cell carcinoma. Curr Opin Urol. 2007;17:331-336.
4. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature. 2007;449:419-426.
5. Matsumoto A, Haraguchi K, Takahashi T, et al. Immuno-therapy against metastatic renal cell carcinoma with mature dendritic cells. Int J Urol. 2007;14:277-283.
6. Kim JH, Lee Y, Bae YS, et al. Phase I/II study of immunotherapy using autologous tumor lysate-pulsed dendritic cells in patients with metastatic renal cell carcinoma. Clin Immunol. 2007;125:257-267.
7. Lim DS, Kim JH, Lee DS, et al. DC immunotherapy is highly effective for the inhibition of tumor metastasis or recurrence, although it is not efficient for the eradication of established solid tumors. Cancer Immunol Immunother. 2007; 56:1817-1829.
8. Driessens G, Hamdane M, Cool V, et al. Highly successful therapeutic vaccinations combining dendritic cells and tumor cells secreting granulocyte macrophage colony-stimulating factor. Cancer Res. 2004;64:8435-8442.
9. Driessens G, Gordower L, Nuttin L, et al. Therapeutic efficacy of antitumor dendritic cell vaccinations correlates with persistent Th1 responses, high intratumor CD8 T-cell recruitment and low relative regulatory T cell infiltration. Cancer Immunol Immunother. 2008;57:1745-1756.
10. Lefranc F, Cool V, Velu T, et al. Granulocyte macrophage-colony stimulating factor gene transfer to induce a protective anti-tumoral immune response against the 9L rat gliosarcoma model. Int J Oncol. 2002;20:1077-1085.
11. Lechanteur C, Moutschen M, Princen F, et al. Antitumoral vaccination with granulocyte-macrophage colony-stimulating factor or interleukin-12-expressing DHD/K12 colon adeno-carcinoma cells. Cancer Gene Ther. 2000;7:676-682.
12. Chagnon F, Thompson-Snipes L, Elhilali M, et al. Murine renal cell carcinoma: evaluation of a dendritic-cell tumour vaccine. BJU Int. 2001;88:418-424.
13. Kinoshita Y, Kono T, Yasumoto R, et al. Antitumor effect on murine renal cell carcinoma by autologous tumor vaccines genetically modified with granulocyte-macrophage colony-stimulating factor and interleukin-6 cells. J Immunother. 2001;24: 205-211.
14. Hege KM, Jooss K, Pardoll D. GM-CSF gene-modified cancer cell immunotherapies: of mice and men. Int Rev Immunol. 2006; 25:321-352.
15. Webster WS, Thompson RH, Harris KJ, et al. Targeting molecular and cellular inhibitory mechanisms for improvement of antitumor memory responses reactivated by tumor cell vaccine. J Immunol. 2007;179:2860-2869.